Bofanglutide: all 25 studies that test it
Page 1 of 1. Open to participants first (11), then studies with results posted, then the rest; newest registration first within each.
- BALANCE-DM2 Study of Bofanglutide in Adults With Type 2 DiabetesNot yet recruitingNCT07628985Phase 3
- BALANCE-OBS: Bofanglutide (GZR18) Versus Semaglutide in Latin American Adults With Overweight or ObesityNot yet recruitingNCT07622810Phase 3
- Evaluate the Efficacy and Safety of GZR18 Injection in Obese Subjects With Obstructive Sleep Apnea Receiving Positive Airway Pressure (PAP) TherapyNot yet recruitingNCT07501832Phase 3
- Evaluate the Efficacy and Safety of GZR18 Injection in Obese Subjects With Obstructive Sleep Apnea Not Treated With Positive Airway Pressure (PAP) TherapyNot yet recruitingNCT07493057Phase 3
- Bioequivalence Study of GZR18 Injection Before and After CMC ChangeRecruitingNCT07355738Phase 1
- Extension Study of the Phase 3 Clinical Study of GZR18 Injection for Weight LossRecruitingNCT07292441Phase 3
- Phase III Clinical Study Comparing the Efficacy and Safety of GZR18 Injection and Semaglutide (Wegovy®) in Adult Obese or Overweight SubjectsRecruitingNCT07150975Phase 3
- Study of Pharmacokinetics and Safety of GZR18 Injection in Subjects With Liver Insufficiency and Normal Liver FunctionRecruitingNCT07144098Phase 1
- Study of Pharmacokinetics and Safety of GZR18 Injection in Subjects With Renal Impairment and Normal Renal FunctionRecruitingNCT07141030Phase 1
- Study on Gastric Emptying Effect and Drug-Drug Interactions of GZR18 InjectionRecruitingNCT07128888Phase 1
- A Phase I Clinical Study to Evaluate the Effect of GZR18 Injection on the Pharmacokinetics of Oral Metformin Hydrochloride Tablets in Overweight/Obese SubjectsNot yet recruitingNCT06670209Phase 1
- The Study of [14C] GZR18CompletedNCT07119450Phase 1
- A Study to Compare the Efficacy and Safety of GZR102 Injection and GZR18 Injection in Type 2 Diabetes MellitusActive, not recruitingNCT07055386Phase 2
- A Phase III Clinical Study to Evaluate the Efficacy and Safety of GZR18 Injection in Adult Type 2 Diabetes MellitusActive, not recruitingNCT06778967Phase 3
- A Phase III Clinical Study to Evaluate the Efficacy and Safety of GZR18 Injection in Subjects With Type 2 Diabetes Mellitus and Poor Blood Glucose Control by Diet and ExerciseActive, not recruitingNCT06777238Phase 3
- Efficacy and Safety of GZR18 Every 2 Weeks Versus Tirzepatide and Placebo in Obese or Overweight ParticipantsCompletedNCT06737042Phase 2
- A Phase III Clinical Study to Evaluate the Efficacy and Safety of GZR18 Injection in Adult Obese/Overweight SubjectsActive, not recruitingNCT06728124Phase 3
- A Study of GZR18 Tablet in Chinese Healthy SubjectsActive, not recruitingNCT06554054Phase 1
- A Phase I Study of GZR18 Injection in Healthy SubjectsCompletedNCT06548997Phase 1
- A Phase I Study of GZR18 Injection in Obese/Overweight SubjectsCompletedNCT06548945Phase 1
- A Study of GZR18 Injection in Obese/Overweight PatientsCompletedNCT06256562Phase 2
- A Study of GZR18 Injection in Chinese Patients With Type 2 Diabetes MellitusActive, not recruitingNCT06256549Phase 2
- A Study of GZR18 Injection in Chinese Obese/Overweight PatientsCompletedNCT06256536Phase 1/2
- A Study of GZR18 Injection in Chinese Adult Patients With Type 2 Diabetes Mellitus (T2DM)CompletedNCT06256523Phase 1/2
- Single, Ascending Dose, First Time in Human Study for GZR18 in Healthy SubjectsCompletedNCT05328726Phase 1